DR. REDDY'S LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,788 INR | -1.52% |
|
-1.31% | -0.18% |
| May. 31 | Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Friday Trading | MT |
| May. 30 | India's pharma export sales to grow faster this year, trade body says | RE |
ETFs positioned on Dr. Reddy's Laboratories Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.02% | 6 M€ | +6.07% | - | |
| 0.33% | 1 M€ | +3.49% | - | |
| 0.33% | 3 M€ | -.--% | - | |
| 0.20% | 11 M€ | +2.67% | ||
| 0.12% | 2,867 M€ | +5.89% | - | |
| 0.12% | 454 M€ | +4.02% | - | |
| 0.12% | 153 M€ | +3.74% | - | |
| 0.10% | 4 M€ | -4.41% | - | |
| 0.05% | 112 M€ | +4.61% | - | |
| 0.05% | 0 M€ | 0.00% | - | |
| 0.04% | 32 M€ | +6.87% | - | |
| 0.03% | 7 M€ | +5.36% | - | |
| 0.03% | 9 M€ | +27.69% | - | |
| 0.02% | 15 M€ | +13.60% | ||
| 0.01% | 34 M€ | +7.50% | - | |
| 0.01% | 45 M€ | -.--% | - | |
| 0.01% | 391 M€ | +7.63% | - | |
| 0.01% | 39 M€ | +5.00% | - | |
| 0.01% | 306 M€ | +5.07% | - | |
| 0.01% | 34 M€ | +3.86% | - | |
| 0.01% | 105 M€ | +2.97% | - | |
| 0.01% | 17 M€ | +2.42% | - | |
| 0.01% | 54 M€ | +0.47% | - | |
| 0.01% | 14 M€ | -5.07% |
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows:
- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;
- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;
- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.
Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
Sector
Pharmaceuticals
Calendar
2024-06-03
- Investor Meeting - Bank of America
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
36
Last Close Price
5,788
INR
Average target price
6,110
INR
Spread / Average Target
+5.58%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.18% | 11.55B | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
- Stock Market
- Equities
- DRREDDY Stock
- Funds and ETFs Dr. Reddy's Laboratories Limited
